AOX1 and non-small cell lung carcinoma: To explore the potential of SCARA5 and AOX1 as epigenetic biomarkers we evaluated the methylation degree of each promoter CpG in NSCLC patients from the TCGA and CURELUNG NSCLC cohorts.